Clinical trial
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform…
NCT00326872 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00326872 |
|---|---|
| Title | AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine |
| Official title | A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma |
| Intervention type | Drug |
| Interventions | Cediranib Maleate |
| Enrollment | 26 |
| Start date | May 1, 2006 |
| Primary completion | Aug 21, 2011 |
| Completion | May 31, 2016 |
| First posted | May 17, 2006 |
| Last update posted | Aug 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: